BEOVU sol inj 6 mg/0.05ml ser préremp 0.165 ml

7680672440019 CH-67244 S01LA06 11.99.0.

Active substances:

BEOVU sol inj 6 mg/0.05ml ser préremp 0.165 ml
BEOVU sol inj 6 mg/0.05ml ser préremp 0.165 ml
BEOVU sol inj 6 mg/0.05ml ser préremp 0.165 ml
1 / 3
google

Details

Product number
6724401
CPT
-
Packaging group
1
Unit
Fertigspritze(n)
Composition
brolucizumabum 120 mg, saccharum, natrii citras anhydricus, polysorbatum 80 0.2 mg, natrii hydroxidum ad pH, aqua ad iniectabile ad solutionem pro 1 ml corresp. natrium 0.82 mg.

Articles (1)

Beovu 120mg/ml, Injektionslösung in Fertigspritze
Injektionslösung in Fertigspritze
1
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
10/07/2026
Professional SmPC
Français
10/07/2026
Professional SmPC
Italien
10/07/2026

Detailed composition

Substance Quantity Type Category
brolucizumabum
120.0 MG Substance Wirkstoff (Principe actif)
saccharum
- Substance HNIDK
natrii citras anhydricus
- Substance HNIDK
polysorbatum 80
0.2 MG Substance HBESI
natrii hydroxidum
- Substance HNIDK
aqua ad iniectabile
- Substance HNIDK
natrium
0.82 MG Substance HBESI

Reimbursement information

Public price
CHF 726.50
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/06/2020

Authorization holder

Novartis Pharma Schweiz AG

6343 Risch

Authorization information

Swissmedic authorization number
67244
Drug name
Beovu, Injektionslösung in Fertigspritze
Galenic form
INLFS
ATC Code
S01LA06
Authorization status
Z
Dispensation category
B
First authorization
16/01/2020
Authorization expiration date
31/12/9999
IT number
11.99.0.
Domain
Human medicine
Field of application
altersbedingte Makuladegeneration (AMD) und diabetisches Makulaödem (DME)

Packaging details

Description (FR)
BEOVU sol inj 6 mg/0.05ml ser préremp 0.165 ml
Description (DE)
BEOVU Inj Lös 6 mg/0.05ml Fertigspr 0.165 ml
Market launch
16/01/2020
Narcotic (BTM)
No
Buy us a coffee Explore the data